Wednesday, April 3 2024
9:10–9:55am
Industry Theater
Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment
Description
GEMTESA is a β3-adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.